Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'

BioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDA

Endpoints NewsUK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says

Endpoints NewsHackers claim they stole Novo Nordisk AI models, manufacturing recipes

Endpoints NewsIn second reversal, FDA gives uniQure a green light to seek accelerated approval

BioPharma DiveJazz zeroes in on next-gen T cell engagers with AbCellera deal

Clinical OMICsVibrating Pill Predicts Anorexia Relapse

FierceBiotechVedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies

FierceBiotechUniQure stock surges after FDA U-turn clears path to gene therapy filing

PharmaVoiceWhy ivermectin is in the limelight again

Clinical OMICsPhilippe Pouletty: Turning Europe’s Life Science Startups Into World Leaders

BioWorldLundbeck patents new orexin OX2 receptor agonists

BioWorldZealand Pharma reports IL-23R antagonists